SeizureHumansCannabidiolChildAnticonvulsantsEpilepsy
Efficacy and safety of cannabidiol in children with developmental and epileptic encephalopathies: A systematic review.
Anna Saranti, Pinelopi Dragoumi, Konstantinos Pavlogiannis, Evangelos Pavlou, Dimitrios Zafeiriou
Published: 202510.1016/j.seizure.2025.10.001
Abstract
BACKGROUND: Developmental and epileptic encephalopathies (DEEs) constitute rare epileptic conditions characterized by treatment-resistant seizures, neurodevelopmental delay, and various comorbidities. None of the currently available drugs have proven…
Preview only. Read the full abstract at the source